Omega-3 fatty acid biochemistry: perspectives from human nutrition

Mil Med. 2014 Nov;179(11 Suppl):82-7. doi: 10.7205/MILMED-D-14-00147.

Abstract

The possibility that western diets poor in omega-3 and rich in omega-6 fatty acids contribute to the increasing burden of chronic diseases including neurological problems is becoming recognized. Modern, westernized diets provide 80 to 90% of polyunsaturated fatty acids as omega-6 linoleic acid (LA) and are depleted in omega-3 fatty acids, giving a distorted balance of LA to α-linoleic acid, and to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). LA intakes exceed Δ-6 desaturase needs for maximal activity. LA accumulates in blood and tissue lipids with increasing intake, and this exacerbates competition between LA and limited omega-3 fatty acids for metabolism and acylation into tissue lipids. Increasing EPA and DHA intake decreases tissue omega-6 fatty acids while also providing EPA and DHA. However, strategies for EPA and DHA supplementation do not address potential underlying problems of omega-6 and omega-3 fatty acid imbalance in the food supply.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Chronic Disease
  • Diet, Western
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / metabolism
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / metabolism
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Omega-3 / metabolism*
  • Fatty Acids, Omega-6 / administration & dosage
  • Fatty Acids, Omega-6 / metabolism
  • Humans
  • Linoleic Acid / administration & dosage
  • Linoleic Acid / metabolism
  • Nutritional Physiological Phenomena
  • Tissue Distribution
  • alpha-Linolenic Acid / administration & dosage
  • alpha-Linolenic Acid / metabolism

Substances

  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • alpha-Linolenic Acid
  • Docosahexaenoic Acids
  • Linoleic Acid
  • Eicosapentaenoic Acid